Skip to main content
. 2022 Mar 18;17(3):e0265476. doi: 10.1371/journal.pone.0265476

Table 6. Patient outcomes by IVDU” History.

Characteristic IVDU Yes
N = 30
IVDU No
N = 77
P-value 1 P-value 2**
Sepsis 2 (6.7) 20 (26.0) 0.41*
Septic Shock 4 (13.3) 17 (22.1)
Previous positive culture (Mean ± SD, Range) 0.8 ± 2.6
(0.0–14.0)
0.9 ± 2.7
(0.0–14.0)
0.30 0.84
Number of positive blood cultures (Mean ± SD, Range) 5.8 ± 4.9
1(0.0–20.0)
4.2 ± 3.5
(1.0–18.0)
0.14 0.21
Fever (⁰C), T MAX (Mean ± SD, Range) 39.1 ± 0.8
(37.9–41.1)
38.5 ± 0.5
(37.3–40.1)
0.29 0.39
Fever duration, days (Mean ± SD, Range) 4.1 ± 5.4
(0.0–25.0)
3.1 ± 4.4
(0.0–29.0)
0.48 0.26
Length of ICU stay, days (Mean ± SD, Range) 2.8 ± 5.4
(0.0–21.0)
4.2 ± 5.7
(0.0–22.0)
0.79
0.29
0.84
Outcome of Infection
    Cured 11 (36.7) 47 (61.0) 0.002
    Expired 4 (13.3) 17 (22.1) 0.003
    Unknown 15 (50.0) 13 (16.9)
Death Date Known (N, %) 4 (3.7) 14(13.1) 0.75
0.77

″Intravenous Drug Use

*P-values in P-value 1 column for categorical variables from chi-squared tests, unless indicated with an asterisk (*) where Fisher’s Exact Test was used; for continuous variables, p-values from Student’s t-test with Satterthwaite adjustment when appropriate.

**P-values in P-value 2 column from Wilcoxon rank-sum tests for non-normal distributions.